查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
手术部位感染控制市场：现况分析与预测（2023-2030）
市场调查报告书
商品编码
1346782

手术部位感染控制市场：现况分析与预测（2023-2030）

Surgical Site Infection Control Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 156 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于全球外科手术数量的增加，预计手术部位感染控制市场将以 4% 左右的速度稳定成长。 全球每年约 3.1 亿例大型手术，其中美国约 4,000 至 5,000 万例，欧洲约 2,000 万例。 有几个因素，包括不良的卫生习惯以及缺乏卫生和消毒，是全世界手术部位感染的主要原因。 除此之外，市场上新产品的推出也推动了预测期内的市场成长。 这将导致全球此类案件的增加。 根据美国医学会杂誌 (JAMA) 发表的事实，大约 0.5% 至 3% 的接受手术的患者会发生手术部位感染。 组织正在采取各种措施来预防这种疾病。 例如，2022 年 11 月，世界卫生组织 (WHO) 更新了预防手术部位感染的全球指南。

根据感染类型，市场分为浅层切口 SSI、深部切口 SSI 和内臟/腔内 SSI。 2022年全球市场中，浅切SSI领域将占据最大份额。 表浅切口 SSI 通常发生在最近接受过手术的身体部位。 征象包括切口部位发红、发热、肿胀、疼痛、引流等局部征候。 为了预防表浅切口 SSI，医院建议在所有类型的手术过程中使用伤口护理敷料、消毒剂和手术巾进行密切观察 30 天。 根据美国国立卫生研究院 2023 年 6 月的报告，在 COVID-19 大流行前后，浅层切口 SSI 最为突出，占 50% 的份额。

依手术方式，市场分为剖腹产手术、胃绕道手术、白内障手术、牙科修復等。 由于全球早产率迅速增加，剖腹产手术预计在预测期内将以高复合年增长率成长。 文化信念和医疗保健品质也在剖腹产的流行中发挥重要作用。 根据世界卫生组织 (WHO) 的报告，全球剖腹产人数不断增加，占新生儿总数的 21% 以上。 预计到 2030 年，将透过剖腹产进行近 29% 的分娩。

产品分为备皮液、手术磨砂膏、剪刀、手术清洁液、手术手套、手术单、手工再处理液、消毒液、医用不织布等。 预计在预测期内，手术手套和消毒剂领域将在市场上占据重要地位。 对微创手术不断增长的需求也是推动这一领域发展的因素。 医疗器材製造商正忙于推出新的医疗产品来满足此类产品的需求。 例如，Mediland 将于 2021 年推出先进的手术台和手术灯。

依最终用途，市场分为医院、门诊手术中心等。 2021年，医院在手术部位感染控制市场中占有很大份额。 这是因为大多数手术是在医院进行的，医院通常采用手术部位感染控制系统。 除此之外，医院数量的增加也支持了该行业的成长。 例如，根据美国医院协会的统计，到2022年，美国将有大约6,100家医院，由非营利组织以及州和地方政府营运的社区医院组成。

为了更了解手术部位感染控制的市场介绍，将市场分为北美（美国、加拿大等北美地区）、欧洲（德国、英国、法国、西班牙、义大利等）欧洲地区）和亚太地区（根据其他地区（中国、日本、印度、亚太其他地区）和其他地区的全球影响力进行分析。 由于患者数量的增加和国内医疗保健提供者的增加，预计北美将在 2022 年占上风。 此外，政府的指导方针和措施也在预测期内推动市场成长。 例如，国家健康与护理卓越研究所 (NICE) 于 2020 年 8 月发布了手术部位感染指南：预防和治疗。 预计在预测期内，该地区对手术部位感染控制措施的需求将会增加。

目录

第 1 章市场介绍

  • 市场定义
  • 主要目标
  • 利害关係人
  • 限制

第 2 章研究方法或假设

  • 调查过程
  • 调查方法
  • 受访者简介

第 3 章市场总结

第 4 章执行摘要

第 5 章 COVID-19 对手术部位感染控制市场的影响

第 6 章手术部位感染控制市场收入，2020-2028

第 7 章依传染病类型划分的市场洞察

  • 浅切口 SSI
  • 深切口SSI
  • 器官或空间 SSI

第 8 章分步市场洞察

  • 剖腹产
  • 胃绕道手术
  • 白内障手术
  • 牙齿修復
  • 其他

第 9 章按产品划分的市场洞察

  • 备皮液
  • 手术磨砂膏
  • 快船
  • 手术清洁
  • 手术手套
  • 手术单
  • 手动后处理设备解决方案
  • 消毒剂
  • 医用不织布
  • 其他

第 10 章最终用途市场洞察

  • 医院
  • 门诊手术中心
  • 其他

第 11 章按地区划分的市场洞察

  • 北美
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区

第 12 章手术部位感染控制的市场动态

  • 市场促进因素
  • 市场挑战
  • 影响分析

第 13 章手术部位感染控制的市场机会

第 14 章手术部位感染控制市场趋势

第 15 章需求方与供给方分析

  • 需求方分析
  • 供给面分析

第 16 章价值链分析

第 17 章竞争场景

  • 竞争状况
    • 波特五力分析

第 18 章公司简介

  • 3M
  • Becton Dickinson, and Company
  • BioMerieux, SA
  • Getinge AB
  • Johnson & Johnson Limited
  • Sotera Health Company
  • Medtronic Private Limited
  • Prescient Surgical
  • GAMA Healthcare Ltd.
  • ANSELL LTD.

第 19 章免责声明

简介目录
Product Code: UMHE212243

Surgical site infections are the kind of infections that originate at the site of invasive surgery. These infections can be superficial, i.e., on the skin or may proliferate to other body organs as well. For the same reason, these infections are one of the major parts of healthcare-associated infections(HCAI). The Centers for Disease Control and Prevention in U.S. has stated tools and guidelines to help patients understand these surgical site infections and take appropriate measures to protect their own health. The basic types of surgical site infections are superficial incisional SSI, deep incisional SSI, and organ or space SSI. Various types of surgeries can cause this situation like caesarean section, gastric bypass, cataract surgery, and dental restoration. There are numerous factors leading to the development of this market, including innovations in standards and infrastructure of the healthcare sector, rising cases of surgical and operating room development worldwide, increase in trends of maintaining hygiene and sanitation. also, surge in government policies for the welfare of public and rise in demand for minimally invasive procedures are driving the growth of the market during the forecast period.

The Surgical Site Infection Control Market is expected to grow at a steady rate of around 4% owing to the increasing surgical procedures globally. An astounding range of 310 million major surgeries are performed each year worldwide; approximately 40 to 50 million in US and nearly 20 million in Europe. Several factors, such as unhygienic practices, lack of sanitation and sterilization are leading causes of surgical site infection globally. Apart from this, the introduction of new products in the market is also driving the market's growth during the forecast period. This leads to an increase in a number of such cases worldwide. Facts stated by The Journal of the American Medical Association (JAMA) convey that surgical site infections Infections occur in nearly 0.5% to 3% of patients going through surgery. Organizations are taking multiple initiatives to help in preventing this ailment. For instance, the World Health Organization has updated its global guidelines for the prevention of surgical site infection in November,2022.

Based on type of infection, the market is segmented into superficial incisional SSI, deep incisional SSI and organ or space SSI. The superficial incisional SSI segment held the maximum share in the global market in 2022. Superficial incisional SSI usually occurs in the body part which has been recently operated. The signs may include localized signs such as redness, heat, swelling at the site of the incision, pain or the drainage of pus. As per hospital advisories, thirty days of strict monitoring is done with the help of wound care dressing, disinfectants, and surgical drapes in all types of surgeries to prevent superficial incisional SSI. According to the reports of the National Institute of Health in June 2023, superficial incisional SSI were most prominent with the share of 50% before as well as after the COVID-19 pandemic.

On the basis of procedure, the market is categorized into cesarean section, gastric bypass, cataract surgery, dental restoration and others. The caesarean section segment is expected to grow with high CAGR during the forecast period due to a surge in the premature deliveries throughout the world. Also cultural believes and healthcare quality could play a pivotal role in promoting the prevalence of C-sections. The World Health Organization reported the continuous rise in caesarean sections globally, there were more than 21% childbirths. It is estimated that nearly 29% of all births in 2030 are expected to take place via cesarean section.

On the basis of product, the market is differentiated into skin preparation solution, surgical scrubs, hair clippers, surgical irrigation, surgical gloves, surgical drapes, manual reprocessors solution, disinfectants, medical nonwovens and others. Surgical- gloves and disinfectants segment were observed to be significant in the market in the forecast period. The rising demand for minimally invasive surgery is also a propelling factor for this segment which is responsible for its prevalence. Medical device companies are engrossed in launching such medical products in demand. For instance, Mediland launches advanced Surgical Table and SurgicalLight in 2021.

Based on the end use, the market is segmented into hospitals, ambulatory surgical centers and others. The hospitals held the significant share in the surgical site infection control market in 2021. This is due to high adoption of surgical site infection control systems in hospitals as most surgeries are performed in hospital settings. Apart from this, the growing number of hospitals is also propelling the segmental growth. For instance, according to the American Hospital Association, there were about 6,100 hospitals in the U.S. in 2022, which comprised of community hospitals run by non-profit organizations as well as state and local governments.

For a better understanding of the market adoption of the surgical site infection control, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is believed to be dominating in 2022 due to the rising number of patients and increasing healthcare providers in the nation. Further, the guidelines and initiatives by government is also driving the market growth during the forecast period. For instance, The National Institute for Health and Care Excellence (NICE) released guidelines regarding surgical site infections: prevention and treatment in August 2020. Over the projection period, this is expected to increase demand for surgical site infection control initiatives in this region.

Some of the major players operating in the market include: 3M; Becton Dickinson, and Company; BioMerieux, SA; Getinge AB; Johnson & Johnson Limited; Sotera Health Company; Medtronic Private Limited; Prescient Surgical; GAMA Healthcare Ltd.; ANSELL LTD.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Surgical Site Infection Control Market
  • 2.2. Research Methodology of the Surgical Site Infection Control Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SURGICAL SITE INFECTION CONTROL MARKET

6 SURGICAL SITE INFECTION CONTROL MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY TYPE OF INFECTION

  • 7.1. Superficial incisional SSI
  • 7.2. Deep incisional SSI
  • 7.3. Organ or space SSI

8 MARKET INSIGHTS BY PROCEDURE

  • 8.1. Caesarean section
  • 8.2. Gastric bypass
  • 8.3. Cataract surgery
  • 8.4. Dental restoration
  • 8.5. Others

9 MARKET INSIGHTS BY PRODUCT

  • 9.1. Skin preparation solution
  • 9.2. Surgical scrubs
  • 9.3. Hair clippers
  • 9.4. Surgical irrigation
  • 9.5. Surgical gloves
  • 9.6. Surgical drapes
  • 9.7. Manual reprocessors solution
  • 9.8. Disinfectants
  • 9.9. Medical nonwovens
  • 9.10. Others

10 MARKET INSIGHTS BY END USE

  • 10.1. Hospitals
  • 10.2. Ambulatory Surgical Centres
  • 10.3. Others

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World

12 SURGICAL SITE INFECTION CONTROL MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 SURGICAL SITE INFECTION CONTROL MARKET OPPORTUNITIES

14 SURGICAL SITE INFECTION CONTROL MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

  • 18.1. 3M
  • 18.2. Becton Dickinson, and Company
  • 18.3. BioMerieux, SA
  • 18.4. Getinge AB
  • 18.5. Johnson & Johnson Limited
  • 18.6. Sotera Health Company
  • 18.7. Medtronic Private Limited
  • 18.8. Prescient Surgical
  • 18.9. GAMA Healthcare Ltd.
  • 18.10. ANSELL LTD.

19 DISCLAIMER